Hazard ratios (95% CI) of developing acute myocardial infarction in patients taking ACEI, ARB, or ACEI/ARB, with no RAS blockade treatment as the control group.

Hazard ratios (95% CI) of developing acute myocardial infarction in patients taking ACEI, ARB, or ACEI/ARB, with no RAS blockade treatment as the control group.本数据集记录了分别服用血管紧张素转换酶抑制剂（Angiotensin Converting Enzyme Inhibitor，ACEI）、血管紧张素Ⅱ受体拮抗剂（Angiotensin Ⅱ Receptor Blocker，ARB）或ACEI/ARB联合疗法的患者发生急性心肌梗死的风险比（95%置信区间，95% CI），并以未接受肾素-血管紧张素系统（Renin-Angiotensin System，RAS）阻断治疗的患者作为对照组。